Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab (Rituxivac)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01707628
Recruitment Status : Completed
First Posted : October 16, 2012
Last Update Posted : January 31, 2014
Information provided by (Responsible Party):
M. Rab, St. Antonius Hospital

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2013
  Actual Study Completion Date : June 2013